The Achieve-3 trial, funded by Eli Lilly, studied more than 1,500 adults with type 2 diabetes from 131 medical research centres and hospitals in Argentina, China, Japan, Mexico and the US
Effectiveness in Appetite Suppression GLP-1 drugs consistently reduce calorie intake by enhancing satiety and reducing hunger
People with certain health conditions, such as chronic kidney disease, and people taking medications like angiotensin-converting enzymes (ACE) inhibitors and angiotensin II receptor blockers (ARBs) may be at a risk for high potassium levels
Medication adherence refers to the extent to which individuals follow prescribed medication regimens, including dosage, timing, and frequency
Serious Risks and When to Call Your Doctor While rare, there are more serious risks to be aware of